...
首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >Thrombin injection for treatment of false aneurysms after failed compression therapy in patients on full-dose antiplatelet and heparin therapy.
【24h】

Thrombin injection for treatment of false aneurysms after failed compression therapy in patients on full-dose antiplatelet and heparin therapy.

机译:接受全剂量抗血小板和肝素治疗的患者在加压治疗失败后使用凝血酶注射液治疗假性动脉瘤。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to gauge the effectiveness of thrombin injection after failed manual compression in patients with false aneurysms receiving full-dose antiplatelet and heparin therapy. In consecutive patients with failed manual compression therapy (ultrasound-guided manual compression, compression bandage, or both), thrombin was injected under ultrasound guidance. In 23 patients, thrombin was injected into the false aneurysm (100-2,000 units; mean, 895 +/- 520 units). All patients were on aspirin (median dose, 100 mg/day), clopidogrel (median dose, 75 mg/day), and either heparin (n = 3) with a partial thromboplastin time (PTT) > 55 sec or weight-adjusted enoxaparine (0.1 ml per 10 kg; maximum, 1 ml/b.i.d.). Twelve patients had received an i.v. GB IIIb/IIa antagonist 11-72 hr prior to diagnosis of the aneurysm. The mean width of the false aneurysms was 20.8 +/- 3.2 mm (range, 8.0-52.0 mm), length 29.7 +/- 32.6 mm (range, 9.0-147 mm), and depth 19 +/- 9.1 mm (range, 5.1-35.5 mm). Thrombosis after thrombin injection occurred in 21 patients within seconds. One patient required a second injection the next day, one patient underwent surgery. Overall success rate was 96%. No in-hospital complications occurred. In patients with false aneurysms and failed compression therapy under full-dose aspirin, clopidogrel, and heparin, selective thrombin injection is highly effective and safe. Cathet Cardiovasc Intervent 2003;58:505-509.
机译:这项研究的目的是评估人工压迫失败后接受全剂量抗血小板和肝素治疗的假性动脉瘤患者中凝血酶注射的有效性。在连续的手动加压疗法失败的患者(超声引导的手动加压,加压绷带或两者兼有)中,在超声引导下注射凝血酶。在23名患者中,凝血酶被注入假动脉瘤(100-2,000单位;平均895 +/- 520单位)。所有患者均接受阿司匹林(中位剂量,每天100毫克),氯吡格雷(中位剂量,每天75毫克)和肝素(n = 3),其中部分凝血活酶时间(PTT)> 55秒或体重调整的依诺肝素(每10千克0.1毫升;最大1毫升/出价)。十二名患者接受了静脉注射诊断动脉瘤之前11-72小时,使用GB IIIb / IIa拮抗剂。假动脉瘤的平均宽度为20.8 +/- 3.2毫米(范围8.0-52.0毫米),长度29.7 +/- 32.6毫米(范围9.0-147毫米)和深度19 +/- 9.1毫米(范围5.1-35.5毫米)。凝血酶注射后的血栓形成几秒钟内发生在21位患者中。一名患者第二天需要第二次注射,一名患者接受了手术。总体成功率为96%。没有发生院内并发症。对于假动脉瘤和在全剂量阿司匹林,氯吡格雷和肝素下进行压缩治疗失败的患者,选择性凝血酶注射是高度有效和安全的。 Cathet Cardiovasc Intervent 2003; 58:505-509。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号